Overview
Status
Active
Registry date
2019-09-17
Share capital
5,000.00 PLN
Registered address
ul. Dr Janusza Korczaka 38/16, 40-341 Katowice, Poland
Financials
Data for 2024 is not shown: the filed document is not a financial statement (e.g. a resolution or a management report).
Industry
Authorized Representatives
Paulina Katarzyna Buczekage 48 – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Paulina Katarzyna Buczekage 48 | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Was a VAT taxpayer from 2019-12-01 to 2023-10-03.
Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| DR ZdrowieS.A. | $43,934,650.47 | drzdrowie.pl | ||
| Dolnośląska Grupa AptecznaS.A. | $30,168,188.68 | dgasa.pl | ||
| Management CompanyS.A. | $21,588,514.42 | managementcompany.pl | ||
| Farmjugsp. z o.o. | $14,506,326.49 | farmjug.pl | ||
| Fragalsp. z o.o. | $5,374,285.81 | aptekafragal.pl | ||
| Adpharmasp. z o.o. | $5,595,917.60 | adamed.com | ||
| Farmjug Agsp. z o.o. | $4,213,734.86 | farmjug.pl | ||
| Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j. | $3,414,382.70 | aptekazielona.com.pl | ||
| Herbarium Świętego Franciszkasp. z o.o. | $1,397,577.12 | herbarium.katowice.pl | ||
| Eurekasp. z o.o. | $1,377,733.77 | fundacja-eureka.edu.pl |
FAQ
The main business activity of Instytut Cb Polska focuses on dispensing chemist in specialised stores.
The company was registered in the Polish National Court Register (KRS) on September 17, 2019.
The headquarters is located at: ul. Dr Janusza Korczaka 38, 40-341 Katowice.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
Last updated: 2026-10-07